These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8743538)

  • 1. C-type natriuretic peptide in chronic renal failure and its action in humans.
    Igaki T; Itoh H; Suga S; Hama N; Ogawa Y; Komatsu Y; Mukoyama M; Sugawara A; Yoshimasa T; Tanaka I; Nakao K
    Kidney Int Suppl; 1996 Jun; 55():S144-7. PubMed ID: 8743538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients.
    Hama N; Itoh H; Shirakami G; Suga S; Komatsu Y; Yoshimasa T; Tanaka I; Mori K; Nakao K
    Biochem Biophys Res Commun; 1994 Feb; 198(3):1177-82. PubMed ID: 8117275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
    Cargill RI; Struthers AD; Lipworth BJ
    Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide.
    Igaki T; Itoh H; Suga SI; Hama N; Ogawa Y; Komatsu Y; Yamashita J; Doi K; Chun TH; Nakao K
    Hypertens Res; 1998 Mar; 21(1):7-13. PubMed ID: 9582102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
    Burnier M; Mooser V; Wauters JP; Marder HK; De Vane P; Nussberger J; Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1989 May; 13(5):682-90. PubMed ID: 2472515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivity and metabolism of C-type natriuretic peptide in normal man.
    Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
    Bentzen H; Pedersen RS; Nyvad O; Pedersen EB
    Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
    Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of heart failure using urinary natriuretic peptides.
    Ng LL; Geeranavar S; Jennings SC; Loke I; O'Brien RJ
    Clin Sci (Lond); 2004 Feb; 106(2):129-33. PubMed ID: 13678415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension.
    Cheung BM; Brown MJ
    J Hypertens; 1994 Apr; 12(4):449-54. PubMed ID: 8064169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of natriuretic peptide system during embryonic stem cell vasculogenesis.
    Doi K; Itoh H; Nakagawa O; Igaki T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Nakao K
    Heart Vessels; 1997; Suppl 12():18-22. PubMed ID: 9476535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients.
    Kohse KP; Feifel K; Mayer-Wehrstein R
    Clin Nephrol; 1993 Aug; 40(2):83-90. PubMed ID: 8222377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure.
    Kalra PR; Clague JR; Coats AJ; Anker SD; Poole-Wilson PA; Struthers AD
    Clin Sci (Lond); 2009 Oct; 118(1):71-7. PubMed ID: 19450232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep.
    Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG
    Am J Physiol; 1996 Jun; 270(6 Pt 2):R1324-31. PubMed ID: 8764300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system.
    Chen HH; Burnett JC
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S22-8. PubMed ID: 9883743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.